News and Announcements
The Israel-Australia Emerging Company Showcase March 2017
- Published March 27, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Events
Wholesale Investor and affiliation with the Israel Trade Commission hosted their very first event together in Singapore! This event took place on Friday, 24th March 2017.
The event featured 17 Leading, Innovative, Award-Winning Emerging Growth Companies from Australia, Israel and Singapore. Spanning from numerous sectorsfeatured like disruptive SaaS, IoT, virtual reality, artificial intelligence, 3D printing & social experience platforms, award-winning fintech, revolutionary pipeline developer, world’s top VC backed medical devices, world-first healthtech, leading biomedical products, mining opportunities, vertically integrated beef operation & many more.
The Showcase had a full turnout of 120+ professional and sophisticated investors, brokers, fund managers and family offices’ , who were captivated by the compelling presentations.
We thank the investors who joined us and the CEO’s in whom presented. At the end of each event, we are humbled by the innovation, persistence and ambition of our clients.
Our next events will be based in Melbourne later today, Sydney on Thursday and London at the beginning of April followed by the Asia-Pacific Emerging Company Investor Roadshow at the beginning of May.
Click on the button below to find out more about our upcoming events or to register!
Events
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
